BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1533 related articles for article (PubMed ID: 25449672)

  • 1. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances of immunological pathogenesis research in HIV related neurocognitive disorder].
    Yongjia JI; Hongzhou LU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(3):249-55. PubMed ID: 27651188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Opioids on HIV Neuropathogenesis.
    Murphy A; Barbaro J; Martínez-Aguado P; Chilunda V; Jaureguiberry-Bravo M; Berman JW
    Front Immunol; 2019; 10():2445. PubMed ID: 31681322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontline Science: CXCR7 mediates CD14
    Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
    J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathogenesis of human immunodeficiency virus infection.
    Sillman B; Woldstad C; Mcmillan J; Gendelman HE
    Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
    Freeman ML; Lederman MM; Gianella S
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.
    Persidsky Y; Gendelman HE
    J Leukoc Biol; 2003 Nov; 74(5):691-701. PubMed ID: 14595004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.
    Eugenin EA; Gamss R; Buckner C; Buono D; Klein RS; Schoenbaum EE; Calderon TM; Berman JW
    J Leukoc Biol; 2006 Mar; 79(3):444-52. PubMed ID: 16507710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.
    Dutta R; Roy S
    J Neuroinflammation; 2015 Jun; 12():120. PubMed ID: 26087960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders.
    Katuri A; Bryant J; Heredia A; Makar TK
    Exp Mol Pathol; 2019 Jun; 108():64-72. PubMed ID: 30922769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alarmins and central nervous system inflammation in HIV-associated neurological disorders.
    Gougeon ML
    J Intern Med; 2017 May; 281(5):433-447. PubMed ID: 27862491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.
    Rizzo MD; Henriquez JE; Blevins LK; Bach A; Crawford RB; Kaminski NE
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):780-793. PubMed ID: 32409991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
    Sui Z; Sniderhan LF; Schifitto G; Phipps RP; Gelbard HA; Dewhurst S; Maggirwar SB
    J Immunol; 2007 Mar; 178(5):3226-36. PubMed ID: 17312171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.
    Yadav A; Collman RG
    J Neuroimmune Pharmacol; 2009 Dec; 4(4):430-47. PubMed ID: 19768553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.
    Grovit-Ferbas K; Harris-White ME
    Immunol Res; 2010 Dec; 48(1-3):40-58. PubMed ID: 20725864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.